This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients (APIs). It features a piperazine ring and a chlorophenyl-substituted cyclohexene core, giving it moderate lipophilicity and a single hydrogen-bond donor.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1228780-72-0
1-((4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride
pharmaceutical intermediate
O-Benzylglycine toluene-p-sulphonate
pharmaceutical intermediate for API synthesis
4-(4-Chlorobutyl)pyridine hydrochloride
pharmaceutical intermediate for API synthesis
4-(Benzyloxycarbonyl)phenylboronic acid
pharmaceutical intermediate for API synthesis
Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo-(2,3-e)pyrazin-8-yl)pyrrolidine-1-carboxylate
pharmaceutical intermediate for API synthesis
Ru(Me-allyl)2(COD)
Pharmaceutical intermediate for ruthenium complexes
6-bromopyridine-2-carbonitrile
pharmaceutical intermediate
(R)-methyl 4-((3R,5S,10S,13R,17R)-10,13-dimethyl-7-oxo-3-(tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
Pharmaceutical intermediate for steroid synthesis
1-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazine
YCNNHDUZLQPKJY-UHFFFAOYSA-N
CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCNCC3)C
—